Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care
暂无分享,去创建一个
S. Wade | U. Gergis | M. Buessing | Si-Tien Wang | J. Snider | S. Johnson | Alice Kate Cummings Joyner